US Schedules Covid-19 Vaccines For Children Below Five Years

In This Article:

  • The U.S. government is preparing to launch vaccines for children below five in conjunction with educational and outreach efforts, pending approval by federal regulators, the Wall Street Journal reports.

  • The government looks to provide ten million initial doses as the virus spreads nationwide, leaving the parents anxious.

  • The vaccinations could begin by June 21, subject to the regulatory approval for Moderna, Inc (NASDAQ: MRNA), Pfizer, Inc (NYSE: PFE), and partner BioNTech SE (NASDAQ: BNTX).

  • Equal amounts of vaccines from Pfizer and Moderna will be available on approval.

  • Five million doses have been made available for preorders by states, community health centers, and pharmacies. Another five million doses will be made available for preorder.

  • The government aimed to make them available through public-health clinics, community health centers, pharmacies including children’s hospitals, health systems, and pop-up clinics at children’s museums.

  • Vaccination rates for children between 5 and 18 years trailed those for older people.

  • An FDA advisory committee will meet on June 14-15 to review the vaccination data, followed by a CDC review on June 17-18.

  • Price Action: MRNA shares traded higher by 1.25% at $150.38 in the premarket on the last check Thursday.

  • Image by x3 from Pixabay

See more from Benzinga

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.